title: Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantation.
authors.affiliation: Department of Surgery, Charité, Virchow-Klinikum, Humboldt-University Berlin, Berlin, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Pfitzmann
authors.forename: J
authors.initials: J
authors.lastname: Klupp
authors.forename: J M
authors.initials: JM
authors.lastname: Langrehr
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: G
authors.initials: G
authors.lastname: Junge
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
authors.forename: T
authors.initials: T
authors.lastname: Steinmüller
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D000284:Administration, Oral; D002908:Chronic Disease; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011184:Postoperative Period; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D016853:Muromonab-CD3; D011239:Prednisolone; D009173:Mycophenolic Acid